Reuben Benjamin
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Hematology top 5%
Papers in
- Oncology 25
- CAR-T cell therapy research 19
- Hematology 14
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Charlotte Graham (6 shared papers)Agnieszka Jóźwik (5 shared papers)Stephen Cobbold (2 shared papers)Herman Waldmann (2 shared papers)Andrea Pepper (2 shared papers)Mike Clark (1 shared paper)Maud Condomines (2 shared papers)Michel Sadelain (2 shared papers)
- Journals
- Blood (7 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (2 papers)HemaSphere (2 papers)The Journal of Gene Medicine (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Reuben Benjamin
42 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 77
- Oncology 472
- Hematology 158
- Immunology 280
- Genetics 100
- Genetics 226
Countries citing papers authored by Reuben Benjamin
This map shows the geographic impact of Reuben Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben Benjamin more than expected).
Fields of papers citing papers by Reuben Benjamin
This network shows the impact of papers produced by Reuben Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben Benjamin. The network helps show where Reuben Benjamin may publish in the future.
Co-authors
The 25 scholars most cited alongside Reuben Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 135 | |
| 2 | 1986 | 124 | |
| 3 | 2009 | 119 | |
| 4 | Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. | 1994 | 72 |
| 5 | 2015 | 55 | |
| 6 | 2012 | 53 | |
| 7 | 2008 | 53 | |
| 8 | 2021 | 45 | |
| 9 | 2005 | 43 | |
| 10 | 2008 | 40 | |
| 11 | 2018 | 32 | |
| 12 | 2007 | 29 | |
| 13 | 2006 | 29 | |
| 14 | 2006 | 24 | |
| 15 | 2013 | 22 | |
| 16 | 1989 | 21 | |
| 17 | 2020 | 21 | |
| 18 | 2022 | 21 | |
| 19 | 2022 | 18 | |
| 20 | 2022 | 18 |
About Reuben Benjamin
Reuben Benjamin is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Genetics, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Multiple Myeloma Research and Treatments (10 papers), Virus-based gene therapy research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Advancements in Semiconductor Devices and Circuit Design (4 papers), Protein Degradation and Inhibitors (3 papers), RNA Interference and Gene Delivery (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Oncology (472 citations), Hematology (158 citations), Immunology (280 citations), Genetics (100 citations) and Genetics (226 citations). Reuben Benjamin has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Charlotte Graham, Agnieszka Jóźwik, Stephen Cobbold, Herman Waldmann, Andrea Pepper, Mike Clark, Maud Condomines, Michel Sadelain, Gertrude Gunset and Kirsty Thomson. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, HemaSphere and The Journal of Gene Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.